Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
|Videos|May 11, 2016
Optimizing Medication Therapy Management in Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Deborah Michaelson, MS, RPh, discusses the elements of an ideal specialty pharmacy therapy management program.
Advertisement
Deborah Michaelson, MS, RPh, discusses the elements of an ideal specialty pharmacy therapy management program.
Advertisement
Related to this article
Doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (Voceryq) targets HPV-6 and HPV-11 to reduce the surgical burden for adults with recurrent respiratory papillomatosis, a rare airway disease.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab Becomes First FDA-Approved Therapy in 10 Years for Pretreated Recurrent or Metastatic HNSCC
2
Understanding Kratom: Pharmacology, Safety, and Regulation
3
CVS Health to Split Into 2 Public Companies, Separating Retail and Specialty Pharmacy
4
AHA 2026: Insights on Oral PCSK9, Survodutide, and HF Care Come to Chicago
5